🔎 Trials Near Me

Akèy › Kansè poumon › Texas › Austin

Etid klinik pou Kansè poumon nan Austin, TX

8 etid pou Kansè poumon ap chèche patisipan nan sit nan ak bò kote Austin (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Ap rekriteFaz 1/2
  • New Experimental Therapeutics - NEXT Oncology, Austin
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Ap rekriteFaz 3
  • Texas Oncology - South Austin, Austin
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06881784

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Ap rekriteFaz 3
  • USO - Texas Oncology, Austin
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • NEXT Oncology - Austin, Austin
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07444814

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Ap rekriteFaz 1/2
  • University of Texas at Austin, Austin
Laj 18 ak plis · Tout sèks · Mizajou May 15, 2026 · NCT05379985

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Elligo Health Research, Inc., Austin
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

Sample Collection for Ongoing Research and Product Evaluation Study

Ap rekriteEtid obsèvasyon
  • Natera, Inc., Austin
Laj 18 ak plis · Tout sèks · Mizajou Jan 15, 2026 · NCT07318051

Etid Kansè poumon nan lòt vil

Lòt etid nan Austin

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.